Avanos Medical Inc (NYSE:AVNS)

$ 15.2 -0.2 (-1.3%) Market Cap: 698.55 Mil Enterprise Value: 811.75 Mil PE Ratio: 44.71 PB Ratio: 0.57 GF Score: 63/100

Q3 2024 Avanos Medical Inc Earnings Call Transcript
Oct 30, 2024

$18.58 (-17.90%)

Earnings
Q2 2024 Avanos Medical Inc Earnings Call Transcript
Jul 31, 2024

$23.92 (+4.18%)

Earnings
Q1 2024 Avanos Medical Inc Earnings Call Transcript
May 02, 2024

$19.71 (+4.90%)

Earnings
Q4 2023 Avanos Medical Inc Earnings Call Transcript
Feb 20, 2024

$19.5 (+1.62%)

Earnings
Avanos Medical Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Q3 2023 Avanos Medical Inc Earnings Call Transcript
Nov 01, 2023

$20.79 (+13.24%)

Earnings
Q2 2023 Avanos Medical Inc Earnings Call Transcript
Aug 09, 2023

$23.41 (-1.47%)

Earnings
Avanos Medical Inc Investor Day Transcript
Jun 20, 2023
Q1 2023 Avanos Medical Inc Earnings Call Transcript
May 03, 2023

$24.44 (-15.61%)

Earnings
Q4 2022 Avanos Medical Inc Earnings Call Transcript
Feb 21, 2023

$29.01 (-3.14%)

Earnings
Avanos Medical Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Q3 2022 Avanos Medical Inc Earnings Call Transcript
Nov 02, 2022

$23.17 (+3.30%)

Earnings
Q2 2022 Avanos Medical Inc Earnings Call Transcript
Aug 09, 2022

$28.84 (+0.95%)

Earnings
Q1 2022 Avanos Medical Inc Earnings Call Transcript
May 04, 2022

$30.73 (+5.28%)

Earnings
Avanos Medical Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Mar 22, 2022
Q4 2021 Avanos Medical Inc Earnings Call Transcript
Feb 23, 2022

$31.69 (+7.39%)

Earnings
Avanos Medical Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Q3 2021 Avanos Medical Inc Earnings Call Transcript
Nov 02, 2021

$32.65 (+2.29%)

Earnings
Avanos Medical Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021
Q2 2021 Avanos Medical Inc Earnings Call Transcript
Aug 03, 2021

$36.93 (-4.08%)

Earnings
Avanos Medical Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Jun 22, 2021
Q1 2021 Avanos Medical Inc Earnings Call Transcript
May 07, 2021

$41.14 (-3.92%)

Earnings
Avanos Medical Inc Annual Shareholders Meeting Transcript
Apr 29, 2021
Q4 2020 Avanos Medical Inc Earnings Call Transcript
Feb 18, 2021

$46.37 (-13.16%)

Earnings
Avanos Medical Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 13, 2021
Q3 2020 Avanos Medical Inc Earnings Call Transcript
Nov 03, 2020

$40.32 (+8.68%)

Earnings
Avanos Medical Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2020
Q2 2020 Avanos Medical Inc Earnings Call Transcript
Aug 04, 2020

$32.5 (+4.37%)

Earnings
Q1 2020 Avanos Medical Inc Earnings Call Transcript
May 06, 2020

$30.36 (+0.70%)

Earnings
Avanos Medical Inc at Barclays Global Healthcare Conference Transcript
Mar 11, 2020
Q4 2019 Avanos Medical Inc Earnings Call Transcript
Feb 25, 2020

$34.41 (+12.45%)

Earnings
Avanos Medical Inc at JPMorgan Healthcare Conference Transcript
Jan 15, 2020
Q3 2019 Avanos Medical Inc Earnings Call Transcript
Nov 05, 2019

$37.08 (-21.67%)

Earnings
Avanos Medical Inc at Morgan Stanley Healthcare Conference Transcript
Sep 09, 2019
Q2 2019 Avanos Medical Inc Earnings Call Transcript
Aug 06, 2019

$37.23 (-1.82%)

Earnings
Q1 2019 Avanos Medical Inc Earnings Call Transcript
May 07, 2019

$43.67 (-6.13%)

Earnings
Avanos Medical Inc at Barclays Global Healthcare Conference Transcript
Mar 13, 2019
Q4 2018 Avanos Medical Inc Earnings Call Transcript
Feb 26, 2019

$50.5 (-1.06%)

Earnings

Q4 2021 Avanos Medical Inc Earnings Call Transcript

Feb 23, 2022 / 02:00PM GMT

Release Date Price: $31.69 (+7.39%)

Transcript 10-K8-K

Operator

Hello, and welcome to the Avanos Fourth Quarter 2021 Earnings Call. (Operator Instructions) Please note, today's event is being recorded.

And now I'd like to turn the conference over to Scott Galovan. Mr. Galovan, please go ahead.

Scott Galovan

Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to the Avanos 2021 Fourth Quarter Earnings Conference Call. Presenting today will be Joe Woody, CEO; and Michael Greiner, Senior Vice President and CFO.

Joe will begin with an update on our quarter and our current business environment as well as recap progress made against our 2021 priorities and key objectives for 2022. Then Michael will review our fourth quarter and full year results and share our 2022 planning assumptions inclusive of our acquisition of OrthogenRx, which closed on January 20. We will finish the call with Q&A. A presentation for today's call is available on the Investors section of our website, avanos.com.

As a reminder, our comments today contain forward-looking statements related to the

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.